Rationale and Design of Therapeutic Angiogenesis by Cell Transplantation Using Adipose-Derived Regenerative Cells in Patients With Critical Limb Ischemia - TACT-ADRC Multicenter Trial.
Shimizu Y., Kondo K., Fukumoto Y., Takamura M., Inoue T., Nagata T.
Prospective Study with a reported sample of 40 on Ankle Injury, Peripheral Artery Disease, published in Circ Rep (2020) — summary generated from the PubMed abstract.
Early human evidence such as case series or small samples is exploring possible benefits.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Prospective Study
- Journal
- Circ Rep (2020)
- Country
- Japan
- Reported sample size
- 40
- Source database
- PubMed
- PMID
- 33693279
- PMCID
- PMC7819646
- DOI
- 10.1253/circrep.CR-20-0055
- Citations
- 5
Abstract (original English)
Background: Despite the growing knowledge regarding optimal treatments for critical limb ischemia (CLI), there are still a considerable number of patients who have to undergo major limb amputation. Intramuscular injection of autologous adipose-derived regenerative cells (ADRCs) in these patients has shown therapeutic potential in improving tissue ischemia, in both preclinical and initial pilot studies. Here, we present a clinical protocol for ADRCs use in a multicenter trial. Methods and Results: The TACT-ADRC multicenter trial is a prospective, interventional, single-arm, open-labeled study at 8 hospitals in Japan, investigating the safety and feasibility of intramuscular injections of ADRCs and testing the hypothesis that this treatment promotes neovascularization and improves major amputation-free survival rates in patients with CLI who have no other treatment option. 40 patients with CLI will be enrolled and followed up from November 2015 to November 2020. Freshly isolated autologous ADRCs will be injected into the target ischemic limbs. Survival rate, adverse events, major limb amputation, ulcer size, 6-min walking distance, numerical rating scale, ankle-brachial pressure index, skin perfusion pressure and digital subtraction angiography will be evaluated at baseline and during 6 months' follow-up. Conclusions: This trial will demonstrate whether implantation of autologous
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
Evidence level
Early human evidence such as case series or small samples is exploring possible benefits.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewPubMed
Cell-Based Therapies for Post-Traumatic Ankle Osteoarthritis and Osteochondral Lesions of the Talus: A Systematic Scoping Review of an Emerging and Heterogeneous Evidence Base.
Systematic Review on Knee Osteoarthritis, Osteoarthritis, Cartilage Damage, Ankle Injury, published in Bioengineering (Basel) (2026) — summary generated from the PubMed abstract.
- 2026
Bioengineering (Basel) - Level ASystematic ReviewPubMed
Platelet-Rich Plasma Injections for Foot and Ankle Pathologies Have Significantly More Complications Compared With Hyaluronic Acid Injections, Saline Solution Injections, and Dry Needling: A Systematic Review.
Systematic Review with a reported sample of 674 on Osteoarthritis, Cartilage Damage, Tendon Injury, Ankle Injury, published in Arthroscopy (2025) — summary generated from the PubMed abstract.
- 2025
- n = 674
Arthroscopy1 citations - Level ASystematic ReviewEurope PMC
Operative management of osteochondral lesions of the talus: 2024 recommendations of the working group 'clinical tissue regeneration' of the German Society of Orthopedics and Traumatology (DGOU)
Systematic Review on Cartilage Damage, Ankle Injury, published in EFORT Open Rev (2024) — summary generated from the PubMed abstract.
- 2024
EFORT Open Rev23 citations - Level AMeta-analysisPubMed
Therapeutic Effect of Stem Cells from Different Sources on Diabetic Foot Ulcers: Systematic Review and Network Meta-Analysis.
Meta-analysis on Ankle Injury, Diabetic Foot, Chronic Wound, published in Int J Low Extrem Wounds (2024) — summary generated from the PubMed abstract.
- 2024
Int J Low Extrem Wounds - Level ASystematic ReviewEurope PMC
Visualized trends and bibliometric analysis in ankle cartilage repair from 2004 to 2024
Systematic Review on Cartilage Damage, Ankle Injury, published in Front Med (Lausanne) (2024) — summary generated from the PubMed abstract.
- 2024
Front Med (Lausanne) - Level ASystematic ReviewPubMed
Adipose-derived stem cells applied to ankle pathologies: a systematic review.
Systematic Review on Osteoarthritis, Cartilage Damage, Ankle Injury, Scar, published in Musculoskelet Surg (2023) — summary generated from the PubMed abstract.
- 2023
Musculoskelet Surg2 citations